| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | W530IRZ40G |
| InChI Key | KEEBLYWBELVGPQ-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C27H23N5O5S2 |
| Molecular Weight | 561.65 |
| AlogP | 5.63 |
| Hydrogen Bond Acceptor | 11.0 |
| Hydrogen Bond Donor | 0.0 |
| Number of Rotational Bond | 8.0 |
| Polar Surface Area | 104.22 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 6.0 |
| Heavy Atoms | 39.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| ANTAGONIST | Proteinase activated receptor 4 antagonist | ClinicalTrials PubMed Other PubMed |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Thrombosis | 2 | D013927 | ClinicalTrials |
| Liver Diseases | 1 | D008107 | ClinicalTrials |
| Ischemic Stroke | 1 | D000083242 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 1478711-48-6 |
| ChEMBL | CHEMBL3716552 |
| DrugBank | DB14942 |
| FDA SRS | W530IRZ40G |
| PubChem | 72188743 |
| SureChEMBL | SCHEMBL15348940 |
| ZINC | ZINC000205663568 |